Ibrahim H. Ersoy

Afyonkarahisar, TR 
Afyonkarahisar, TR 
OverviewLocationsClinical Research

Overview

Ibrahim Ersoy practices in Afyonkarahisar, Turkey. His top areas of expertise are Infective Endocarditis, Endocarditis, Atrial Fibrillation, Mitral Valve Prolapse, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 35 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Afyonkarahisar, Turkey
Other Locations
Antalya, Turkey
Kepez, 07320, Turkey
Bucak, Turkey
Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Effects of N-acetyl Cysteine on Periprocedural Myocardial Infarction and Major Cardiac and Cerebral Events in Patients Undergoing Percutaneous Coronary Intervention
Effects of N-acetyl Cysteine on Periprocedural Myocardial Infarction and Major Cardiac and Cerebral Events in Patients Undergoing Percutaneous Coronary Intervention
Enrollment Status: Active_not_recruiting
Publish Date: May 20, 2025
Intervention Type: Drug
Study Drugs: N-acetyl Cysteine, Saline
Study Phase: Phase 3
Effects of N-acetyl Cysteine on Major Cardiac and Cerebral Events in Patients Undergoing Primary Percutaneous Coronary Intervention Who Have Moderate to High Risk For Contrast Induced Nephropathy
Effects of N-acetyl Cysteine on Major Cardiac and Cerebral Events in Patients Undergoing Primary Percutaneous Coronary Intervention Who Have Moderate to High Risk For Contrast Induced Nephropathy
Enrollment Status: Active_not_recruiting
Publish Date: May 20, 2025
Intervention Type: Drug
Study Phase: Phase 3
Does Cardioversion of Atrial Fibrillation Increase the Risk of Stroke and Silent Cerebrovascular Thromboembolism? Comparison of the Two Cardioversion Methods
Does Cardioversion of Atrial Fibrillation Increase the Risk of Stroke and Silent Cerebrovascular Thromboembolism? Comparison of the Two Cardioversion Methods
Enrollment Status: Completed
Publish Date: November 15, 2024
Intervention Type: Drug, Procedure
Study Drug: Anticoagulant
Study Phase: Phase 3
View 2 Less Clinical Trials

35 Total Publications

Immediate Pericardial Protamine Administration During Uncontrollable Acute Iatrogenic Hemorrhagic Cardiac Tamponade: A Safety and Feasibility Study.
Immediate Pericardial Protamine Administration During Uncontrollable Acute Iatrogenic Hemorrhagic Cardiac Tamponade: A Safety and Feasibility Study.
Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
Published: June 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ersoy's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile